A detailed history of Wellington Shields Capital Management, LLC transactions in Edwards Lifesciences Corp stock. As of the latest transaction made, Wellington Shields Capital Management, LLC holds 67,832 shares of EW stock, worth $5.07 Million. This represents 0.8% of its overall portfolio holdings.

Number of Shares
67,832
Previous 79,232 14.39%
Holding current value
$5.07 Million
Previous $7.32 Million 38.84%
% of portfolio
0.8%
Previous 1.36%

Shares

25 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

SELL
$59.7 - $93.78 $680,580 - $1.07 Million
-11,400 Reduced 14.39%
67,832 $4.48 Million
Q2 2024

Aug 05, 2024

SELL
$84.3 - $94.31 $32,877 - $36,780
-390 Reduced 0.49%
79,232 $7.32 Million
Q1 2024

May 03, 2024

SELL
$72.54 - $95.56 $170,831 - $225,043
-2,355 Reduced 2.87%
79,622 $7.61 Million
Q4 2023

Feb 09, 2024

SELL
$61.71 - $77.76 $2.42 Million - $3.05 Million
-39,252 Reduced 32.38%
81,977 $6.25 Million
Q3 2023

Nov 14, 2023

BUY
$69.28 - $93.38 $12,124 - $16,341
175 Added 0.14%
121,229 $8.4 Million
Q2 2023

Aug 11, 2023

SELL
$81.41 - $94.33 $12.2 Million - $14.1 Million
-149,581 Reduced 55.27%
121,054 $11.4 Million
Q1 2023

May 11, 2023

BUY
$74.26 - $84.51 $929,438 - $1.06 Million
12,516 Added 4.85%
270,635 $22.4 Million
Q4 2022

Feb 14, 2023

SELL
$68.3 - $87.44 $985,978 - $1.26 Million
-14,436 Reduced 5.3%
258,119 $19.3 Million
Q3 2022

Nov 14, 2022

SELL
$82.37 - $107.29 $1.8 Million - $2.34 Million
-21,828 Reduced 7.41%
272,555 $10.4 Million
Q2 2022

Aug 12, 2022

SELL
$86.5 - $128.27 $3.55 Million - $5.26 Million
-41,034 Reduced 12.23%
294,383 $11.9 Million
Q1 2022

May 12, 2022

BUY
$101.96 - $128.34 $21.5 Million - $27.1 Million
210,796 Added 169.15%
335,417 $14.8 Million
Q4 2021

Feb 15, 2022

SELL
$106.37 - $130.68 $267,201 - $328,268
-2,512 Reduced 1.98%
124,621 $16.1 Million
Q3 2021

Nov 10, 2021

SELL
$102.91 - $122.75 $295,557 - $352,538
-2,872 Reduced 2.21%
127,133 $14.4 Million
Q2 2021

Aug 13, 2021

BUY
$83.84 - $104.76 $83 - $104
1 Added 0.0%
130,005 $13.5 Million
Q1 2021

May 12, 2021

SELL
$78.68 - $90.67 $15,736 - $18,134
-200 Reduced 0.15%
130,004 $10.9 Million
Q4 2020

Feb 09, 2021

SELL
$71.69 - $91.23 $261,381 - $332,624
-3,646 Reduced 2.72%
130,204 $11.9 Million
Q3 2020

Nov 10, 2020

BUY
$67.19 - $87.44 $53,752 - $69,952
800 Added 0.6%
133,850 $10.7 Million
Q2 2020

Aug 05, 2020

BUY
$57.54 - $76.95 $5.1 Million - $6.83 Million
88,700 Added 200.0%
133,050 $9.2 Million
Q1 2020

May 07, 2020

SELL
$52.41 - $81.0 $38,521 - $59,535
-735 Reduced 1.63%
44,350 $8.37 Million
Q4 2019

Feb 11, 2020

SELL
$71.7 - $82.09 $50,190 - $57,463
-700 Reduced 1.53%
45,085 $10.5 Million
Q2 2019

Aug 08, 2019

SELL
$55.74 - $64.41 $2,787 - $3,220
-50 Reduced 0.11%
45,785 $8.46 Million
Q4 2018

Feb 11, 2019

SELL
$46.41 - $56.94 $116,024 - $142,350
-2,500 Reduced 5.17%
45,835 $7.02 Million
Q2 2018

Aug 02, 2018

SELL
$42.45 - $51.3 $46,907 - $56,686
-1,105 Reduced 2.24%
48,335 $7.04 Million
Q4 2017

Feb 06, 2018

BUY
$33.79 - $39.39 $23,653 - $27,573
700 Added 1.44%
49,440 $5.57 Million
Q3 2017

Nov 06, 2017

BUY
$36.29 - $38.83 $1.77 Million - $1.89 Million
48,740
48,740 $5.33 Million

Others Institutions Holding EW

About Edwards Lifesciences Corp


  • Ticker EW
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 618,259,968
  • Market Cap $46.3B
  • Description
  • Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...
More about EW
Track This Portfolio

Track Wellington Shields Capital Management, LLC Portfolio

Follow Wellington Shields Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wellington Shields Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Wellington Shields Capital Management, LLC with notifications on news.